Tekcapital portfolio company Belluscura (LON:BELL) have provided an update on the roll-out of their portable oxygen devices, alongside the announcement of a distribution agreement with a leading US supplier. Tekcapital has a 14% stake in AIM-listed Belluscura, currently valued in the region of £11m.

Download your research report now for instant access.

Download Report

Please read the High Net Worth Individual Statement or Sophisticated Investor Statement before downloading this guide.